MUSA Q1 2026 Earnings EPS Surges 415 Above Estimates Stock Slightly Declines UiPath Q1 2026 Earnings EPS Beat Drives Positive Sentiment Despite Revenue Ambiguity Sensient Technologies Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction QMCO Q1 2026 Earnings EPS Beat Estimates but Stock Declines as Revenue Remains Unreported GBR Q3 2023 Earnings Minimal Earnings Reported as Stock Declines Pulse Biosciences PLSE Shows Modest Gain as Stock Holds Above Key Support Aclarion Inc ACON Slips 156 as Shares Approach Key Support at 30 Personalis Inc PSNL Surges 77 as Precision Medicine Stock Approaches Key Resistance Elicio Therapeutics ELTX Bounces 45 as Biotech Sentiment Improves CNH Q1 2026 Earnings EPS Beats Estimates by 75 Stock Declines Slightly Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrowing Losses Overshadowed by Flat Drug Pipeline Anavex Life Sciences Corp AVXL Q1 2026 Earnings NarrowerThanExpected Loss Amid PreRevenue Pipeline Progress zSpace Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent APPN Q1 2026 Earnings EPS Surges Past Estimates with 44 Beat KNSA Q1 2026 Earnings EPS Surpasses Estimates by 315 Despite Stock Decline NATH Q4 2024 Earnings EPS of 096 Reported Amid Modest Stock Reaction